Literature DB >> 23358111

Matrix metalloproteinase-9 of tubular and macrophage origin contributes to the pathogenesis of renal fibrosis via macrophage recruitment through osteopontin cleavage.

Thian Kui Tan1, Guoping Zheng, Tzu-Ting Hsu, So Ra Lee, Jianlin Zhang, Ye Zhao, Xinrui Tian, Yiping Wang, Yuan Min Wang, Qi Cao, Ya Wang, Vincent W S Lee, Changqi Wang, Dong Zheng, Stephen I Alexander, Erik Thompson, David C H Harris.   

Abstract

A pro-fibrotic role of matrix metalloproteinase-9 (MMP-9) in tubular cell epithelial-mesenchymal transition (EMT) is well established in renal fibrosis; however studies from our group and others have demonstrated some previously unrecognized complexity of MMP-9 that has been overlooked in renal fibrosis. Therefore, the aim of this study was to determine the expression pattern, origin and the exact mechanism underlying the contribution of MMP-9 to unilateral ureteral obstruction (UUO), a well-established model of renal fibrosis via MMP-9 inhibition. Renal MMP-9 expression in BALB/c mice with UUO was examined on day 1, 3, 5, 7, 9, 11 and 14. To inhibit MMP-9 activity, MMP-2/9 inhibitor or MMP-9-neutralizing antibody was administered daily for 4 consecutive days from day 0-3, 6-9 or 10-13 and tissues harvested at day 14. In UUO, there was a bi-phasic early- and late-stage upregulation of MMP-9 activity. Interestingly, tubular epithelial cells (TECs) were the predominant source of MMP-9 during early stage, whereas TECs, macrophages and myofibroblasts produced MMP-9 during late-stage UUO. Early- and late-stage inhibition of MMP-9 in UUO mice significantly reduced tubular cell EMT and renal fibrosis. Moreover, MMP-9 inhibition caused a significant reduction in MMP-9-cleaved osteopontin and macrophage infiltration in UUO kidney. Our in vitro study showed MMP-9-cleaved osteopontin enhanced macrophage transwell migration and MMP-9 of both primary TEC and macrophage induced tubular cell EMT. In summary, our result suggests that MMP-9 of both TEC and macrophage origin may directly or indirectly contribute to the pathogenesis of renal fibrosis via osteopontin cleavage, which, in turn further recruit macrophage and induce tubular cell EMT. Our study also highlights the time dependency of its expression and the potential of stage-specific inhibition strategy against renal fibrosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23358111     DOI: 10.1038/labinvest.2013.3

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  57 in total

Review 1.  Inflammatory processes in renal fibrosis.

Authors:  Xiao-Ming Meng; David J Nikolic-Paterson; Hui Yao Lan
Journal:  Nat Rev Nephrol       Date:  2014-07-01       Impact factor: 28.314

2.  Connective tissue growth factor (CCN2) is a matricellular preproprotein controlled by proteolytic activation.

Authors:  Ole Jørgen Kaasbøll; Ashish K Gadicherla; Jian-Hua Wang; Vivi Talstad Monsen; Else Marie Valbjørn Hagelin; Meng-Qiu Dong; Håvard Attramadal
Journal:  J Biol Chem       Date:  2018-09-27       Impact factor: 5.157

Review 3.  Renal fibrosis: Primacy of the proximal tubule.

Authors:  Leslie S Gewin
Journal:  Matrix Biol       Date:  2018-02-06       Impact factor: 11.583

4.  Mesenchymal Stem Cells Deliver Exogenous MicroRNA-let7c via Exosomes to Attenuate Renal Fibrosis.

Authors:  Bo Wang; Kevin Yao; Brooke M Huuskes; Hsin-Hui Shen; Junli Zhuang; Catherine Godson; Eoin P Brennan; Jennifer L Wilkinson-Berka; Andrea F Wise; Sharon D Ricardo
Journal:  Mol Ther       Date:  2016-05-18       Impact factor: 11.454

5.  Saturated fatty acids bound to albumin enhance osteopontin expression and cleavage in renal proximal tubular cells.

Authors:  Alyssa Cobbs; Kristopher Ballou; Xiaoming Chen; Jasmine George; Xueying Zhao
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2018-03-10

Review 6.  The pathogenesis and management of renal scarring in children with vesicoureteric reflux and pyelonephritis.

Authors:  Vasikar Murugapoopathy; Christine McCusker; Indra R Gupta
Journal:  Pediatr Nephrol       Date:  2019-03-07       Impact factor: 3.714

7.  Matrix metalloproteinases in ureteropelvic junction obstruction.

Authors:  A Pavlaki; N Printza; E Farmaki; S Stabouli; A Taparkou; J Dotis; F Papachristou
Journal:  Hippokratia       Date:  2017 Jul-Sep       Impact factor: 0.471

8.  Alternatively activated macrophages in the pathogenesis of chronic kidney allograft injury.

Authors:  Yohei Ikezumi; Toshiaki Suzuki; Takeshi Yamada; Hiroya Hasegawa; Utako Kaneko; Masanori Hara; Toshio Yanagihara; David J Nikolic-Paterson; Akihiko Saitoh
Journal:  Pediatr Nephrol       Date:  2014-12-09       Impact factor: 3.714

Review 9.  Extracellular matrix roles in cardiorenal fibrosis: Potential therapeutic targets for CVD and CKD in the elderly.

Authors:  Hiroe Toba; Merry L Lindsey
Journal:  Pharmacol Ther       Date:  2018-08-25       Impact factor: 12.310

10.  Matrix metalloproteinase 9 is associated with peritoneal membrane solute transport and induces angiogenesis through β-catenin signaling.

Authors:  Manreet Padwal; Imad Siddique; Lili Wu; Katelynn Tang; Felix Boivin; Limin Liu; Jennifer Robertson; Darren Bridgewater; Judith West-Mays; Azim Gangji; Kenneth Scott Brimble; Peter J Margetts
Journal:  Nephrol Dial Transplant       Date:  2017-01-01       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.